[Hemosorption in the complex treatment of arteriosclerotic dyscirculatory encephalopathy associated with chronic ischemic heart disease]. 1986

A I Fedin, and O V Zhbankova, and A S Blagosklonov, and E B Teterina, and V A Simonov

Hemosorption was included in combined treatment of 110 patients with atherosclerotic dyscirculatory encephalopathy combined with coronary heart disease. The effect was assessed on the basis of clinical improvement, psychological tests, blood lipid assays, compressed spectral EEG analysis and ultrasonic flowmetry of the carotid arteries. The effectiveness of hemosorption was demonstrated at all stages of the disease, with the regression of general cerebral and focal neurologic symptoms preceding clinical remission of coronary heart disease. Hemosorption was shown to have good effects on blood lipids, cerebral circulation and EEG spectrograms.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002537 Intracranial Arteriosclerosis Vascular diseases characterized by thickening and hardening of the walls of ARTERIES inside the SKULL. There are three subtypes: (1) atherosclerosis with fatty deposits in the ARTERIAL INTIMA; (2) Monckeberg's sclerosis with calcium deposits in the media and (3) arteriolosclerosis involving the small caliber arteries. Clinical signs include HEADACHE; CONFUSION; transient blindness (AMAUROSIS FUGAX); speech impairment; and HEMIPARESIS. Cerebral Arteriosclerosis,Intracranial Atherosclerosis,Cerebral Atherosclerosis,Arterioscleroses, Cerebral,Arterioscleroses, Intracranial,Arteriosclerosis, Cerebral,Arteriosclerosis, Intracranial,Atheroscleroses, Cerebral,Atheroscleroses, Intracranial,Atherosclerosis, Cerebral,Atherosclerosis, Intracranial,Cerebral Arterioscleroses,Cerebral Atheroscleroses,Intracranial Arterioscleroses,Intracranial Atheroscleroses
D002545 Brain Ischemia Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. Cerebral Ischemia,Ischemic Encephalopathy,Encephalopathy, Ischemic,Ischemia, Cerebral,Brain Ischemias,Cerebral Ischemias,Ischemia, Brain,Ischemias, Cerebral,Ischemic Encephalopathies
D002606 Charcoal An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. (Grant & Hackh's Chemical Dictionary, 5th ed) Activated Charcoal,Actidose,Actidose-Aqua,Adsorba,Carbomix,Charbon,CharcoAid,CharcoCaps,Charcodote,Formocarbine,Insta-Char,Kohle-Compretten,Kohle-Hevert,Kohle-Pulvis,Kohle-Tabletten Boxo-Pharm,Liqui-Char,Norit,Ultracarbon,Charcoal, Activated
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006464 Hemoperfusion Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). Hemosorption,Hemoperfusions,Hemosorptions

Related Publications

A I Fedin, and O V Zhbankova, and A S Blagosklonov, and E B Teterina, and V A Simonov
January 1991, Sovetskaia meditsina,
A I Fedin, and O V Zhbankova, and A S Blagosklonov, and E B Teterina, and V A Simonov
October 1986, Kardiologiia,
A I Fedin, and O V Zhbankova, and A S Blagosklonov, and E B Teterina, and V A Simonov
September 2000, Likars'ka sprava,
A I Fedin, and O V Zhbankova, and A S Blagosklonov, and E B Teterina, and V A Simonov
January 2012, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
A I Fedin, and O V Zhbankova, and A S Blagosklonov, and E B Teterina, and V A Simonov
July 1985, Klinicheskaia meditsina,
A I Fedin, and O V Zhbankova, and A S Blagosklonov, and E B Teterina, and V A Simonov
June 1989, Kardiologiia,
A I Fedin, and O V Zhbankova, and A S Blagosklonov, and E B Teterina, and V A Simonov
August 1989, Klinicheskaia meditsina,
A I Fedin, and O V Zhbankova, and A S Blagosklonov, and E B Teterina, and V A Simonov
July 1989, Vrachebnoe delo,
A I Fedin, and O V Zhbankova, and A S Blagosklonov, and E B Teterina, and V A Simonov
November 1978, Sovetskaia meditsina,
A I Fedin, and O V Zhbankova, and A S Blagosklonov, and E B Teterina, and V A Simonov
January 2002, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova,
Copied contents to your clipboard!